Cargando…
Retracted: Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with EGFR-Mutated Non-Small-Cell Lung Cancer Regardless of Cerebrospinal Fluid T790M Mutational Status
Autor principal: | and Alternative Medicine, Evidence-Based Complementary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356200/ https://www.ncbi.nlm.nih.gov/pubmed/37476338 http://dx.doi.org/10.1155/2023/9789654 |
Ejemplares similares
-
Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with EGFR-Mutated Non-Small-Cell Lung Cancer Regardless of Cerebrospinal Fluid T790M Mutational Status
por: Zhang, Milan, et al.
Publicado: (2021) -
Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Analysis of Clinical Manifestations, Imaging Features, and Gene Mutation Characteristics of 6 Children with Cystic Fibrosis in China
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Synchronous Colorectal Liver Metastases considering Infectious Complications: Simultaneous or Delayed Surgery?
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
Retracted: Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)